• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的短期生存情况:马来亚大学医学中心的经验

Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre.

作者信息

Ong Teng Aik, Yip Cheng Har

机构信息

Department of Surgery, Faculty of Medicine and Health Sciences, University Malaysia Sarawak, Kuching, Sarawak, Malaysia.

出版信息

Asian J Surg. 2003 Jul;26(3):169-75. doi: 10.1016/S1015-9584(09)60378-X.

DOI:10.1016/S1015-9584(09)60378-X
PMID:12925293
Abstract

OBJECTIVE

To study the impact of various clinicopathological factors on short-term survival in a cohort of breast cancer patients treated at the University of Malaya Medical Centre (UMMC).

METHODS

All cases of breast cancer treated at UMMC from January 1999 to June 2001, except for stage IV disease, were included in the study. Survival analysis was carried out using Kaplan-Meier for univariate analysis and Cox regression for multivariate analysis. The log-rank test was used to test the significance of differences between the different survival curves.

RESULTS

A total of 385 patients were included. The mean patient age at presentation was 50.3 years (SD, 11.4); 198 (51.4%) patients had lymph node-positive disease, and 187 (48.6%) had node-negative disease. The mean follow-up period was 18.7 months (SD, 8.8). The Malay ethnic group, tumours of larger size, node-positive disease, more than five positive lymph nodes, oestrogen receptor (ER) negativity and the presence of lymphovascular invasion were significant prognostic factors for shorter recurrence-free survival (RFS) in the univariate analysis. In the multivariate analysis, ER negativity was the only independent adverse prognostic factor for RFS. For overall survival (OS), tumours of larger size, node-positive disease, more than five positive lymph nodes, ER negativity and high grade tumours were associated with significantly shorter OS. However, more than five positive lymph nodes was the only independent prognostic factor for shorter OS in the multivariate analysis. Further multivariate analysis of the patients with node-positive disease showed that the Malay ethnic group, ER negativity and more than five positive lymph nodes were independent prognostic factors for shorter RFS. On the other hand, ER negativity and more than five positive lymph nodes were independent negative prognostic factors for OS in this subgroup of patients.

CONCLUSION

The evaluation of various prognostic factors would provide useful information on disease progression in local patients, especially for the planning of adjuvant therapies and follow-up protocols. Differences in the pattern of breast cancer among the different ethnic groups in Malaysia warrant further studies.

摘要

目的

研究多种临床病理因素对在马来亚大学医学中心(UMMC)接受治疗的一组乳腺癌患者短期生存的影响。

方法

纳入1999年1月至2001年6月在UMMC接受治疗的所有乳腺癌病例,但IV期疾病除外。采用Kaplan-Meier法进行单因素生存分析,采用Cox回归进行多因素分析。采用对数秩检验来检验不同生存曲线之间差异的显著性。

结果

共纳入385例患者。患者就诊时的平均年龄为50.3岁(标准差,11.4);198例(51.4%)患者有淋巴结阳性疾病,187例(48.6%)有淋巴结阴性疾病。平均随访期为18.7个月(标准差,8.8)。在单因素分析中,马来族、肿瘤较大、淋巴结阳性疾病、五个以上阳性淋巴结、雌激素受体(ER)阴性以及存在淋巴管浸润是无复发生存期(RFS)较短的显著预后因素。在多因素分析中,ER阴性是RFS唯一独立的不良预后因素。对于总生存期(OS),肿瘤较大、淋巴结阳性疾病、五个以上阳性淋巴结、ER阴性和高级别肿瘤与显著较短的OS相关。然而,在多因素分析中,五个以上阳性淋巴结是OS较短的唯一独立预后因素。对淋巴结阳性疾病患者进行的进一步多因素分析表明,马来族、ER阴性和五个以上阳性淋巴结是RFS较短的独立预后因素。另一方面,在该亚组患者中,ER阴性和五个以上阳性淋巴结是OS的独立阴性预后因素。

结论

对各种预后因素的评估将为当地患者的疾病进展提供有用信息,特别是在辅助治疗计划和随访方案方面。马来西亚不同种族间乳腺癌模式的差异值得进一步研究。

相似文献

1
Short-term survival in breast cancer: the experience of the University of Malaya Medical Centre.乳腺癌的短期生存情况:马来亚大学医学中心的经验
Asian J Surg. 2003 Jul;26(3):169-75. doi: 10.1016/S1015-9584(09)60378-X.
2
C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.马来西亚国民大学医学中心乳腺癌中C-erbB-2癌蛋白表达:与肿瘤特征及短期生存的关系
Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):663-70.
3
The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.淋巴结比率作为非转移性淋巴结阳性乳腺癌复发和死亡率的独立预后因素。
J BUON. 2015 May-Jun;20(3):737-45.
4
Prognostic factors for elderly breast cancer patients in University Malaya Medical Centre, Malaysia.马来西亚马来亚大学医学中心老年乳腺癌患者的预后因素。
Asian Pac J Cancer Prev. 2010;11(5):1205-11.
5
[Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].腹股沟淋巴结转移乳腺癌患者的临床病理特征及预后因素:附17例报告
Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):207-11. doi: 10.3760/cma.j.issn.0253-3766.2013.03.010.
6
Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre.马来西亚乳腺癌女性的生存分析:来自马来亚大学医学中心的结果。
Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):197-202.
7
[Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].10枚及以上阳性淋巴结的女性乳腺癌患者的临床特征及预后因素:128例报告
Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):77-81.
8
Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma.尿激酶型纤溶酶原激活剂与其1型抑制剂的复合物预示576例淋巴结阴性乳腺癌患者预后不良。
Cancer. 2004 Aug 1;101(3):486-94. doi: 10.1002/cncr.20374.
9
Improvement in survival of breast cancer patients - trends over two time periods in a single institution in an Asia Pacific country, Malaysia.马来西亚这个亚太国家的一家机构内,乳腺癌患者生存率的改善——两个时间段的趋势
Asian Pac J Cancer Prev. 2011;12(2):345-9.
10
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.腋窝淋巴结转移阳性率可预测非转移性乳腺癌患者的生存率。
Acta Oncol. 2008;47(2):232-8. doi: 10.1080/02841860701678761.

引用本文的文献

1
Development of electronic medical records for clinical and research purposes: the breast cancer module using an implementation framework in a middle income country- Malaysia.为临床和研究目的开发电子病历:在中等收入国家马来西亚使用实施框架的乳腺癌模块。
BMC Bioinformatics. 2019 Feb 4;19(Suppl 13):402. doi: 10.1186/s12859-018-2406-9.
2
Systematic review of breast cancer biology in developing countries (part 2): asian subcontinent and South East Asia.发展中国家乳腺癌生物学的系统评价(第 2 部分):亚洲次大陆和东南亚。
Cancers (Basel). 2011 May 13;3(2):2382-401. doi: 10.3390/cancers3022382.